On ECHEMI
Home > Drugs > Changzhou Pharmaceutical Factory Co., Ltd.
Changzhou Pharmaceutical Factory Co., Ltd.
  • Founded in:

    2001-12-14
  • Country:

    China China
  • Address:

    No. 518, Laodong East Road, Changzhou
  • Tax NO.:

    91320400137158490L
  • Registered Funds:

    108 million yuan
  • Website:

  • Email:

Related Drugs
Ibuprofen tablets
Ibuprofen
Name Description Content CAS NO. Registered Holders
Ibuprofen

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

15687-27-1 54
Folic acid tablets
Each tablet of this product contains 0.4 mg of folic acid. Excipients are: starch, lactose, magnesium stearate.
Name Description Content CAS NO. Registered Holders
Folic acid

Folic acid is a water-soluble B vitamin composed of pteridine, p-aminobenzoic acid and glutamic acid residues. It is an essential substance for the growth and reproduction of body cells. It participates in many important reactions in the body and the synthesis of nucleic acids and amino acids, promotes cell DNA synthesis, and promotes cell division and maturation.

More

Folic acid is a water-soluble B vitamin composed of pteridine, p-aminobenzoic acid and glutamic acid residues. It is an essential substance for the growth and reproduction of body cells. It participates in many important reactions in the body and the synthesis of nucleic acids and amino acids, promotes cell DNA synthesis, and promotes cell division and maturation.

0.4mg 59-30-3 17
Clonidine Hydrochloride
Name Description Content CAS NO. Registered Holders
Clonidine hydrochloride

Extract from the above information

More

Extract from the above information

4205-91-8 23
Captopril Tablets
The main component of this product and its chemical name is: 1-[(2S)-2-methyl-3-mercapto-1-oxypropyl]-L-proline. Its structural formula is: Molecular formula: C9H15NO3S Molecular weight: 217.29
Name Description Content CAS NO. Registered Holders
1-[(2S)-2-methyl-3-mercapto-1-oxypropyl]-L-proline

This product is a competitive angiotensin converting enzyme inhibitor, which prevents angiotensin I from converting into angiotensin II, thereby reducing peripheral vascular resistance and reducing water and sodium retention by inhibiting aldosterone secretion. This product can also dilate peripheral blood vessels by interfering with the degradation of bradykinin. For patients with heart failure, this product can also reduce pulmonary capillary wedge pressure and pulmonary vascular resistance, increase cardiac output and exercise tolerance time.

More

This product is a competitive angiotensin converting enzyme inhibitor, which prevents angiotensin I from converting into angiotensin II, thereby reducing peripheral vascular resistance and reducing water and sodium retention by inhibiting aldosterone secretion. This product can also dilate peripheral blood vessels by interfering with the degradation of bradykinin. For patients with heart failure, this product can also reduce pulmonary capillary wedge pressure and pulmonary vascular resistance, increase cardiac output and exercise tolerance time.

0
Hydrochlorothiazide Tablets
Hydrochlorothiazide.
Name Description Content CAS NO. Registered Holders
Hydrochlorothiazide

1. Effect on water and electrolyte excretion. ① Diuretic effect, increased excretion of urinary sodium, potassium, chloride, phosphorus and magnesium ions, and reduced excretion of urinary calcium. The mechanism of action of this type of drug is mainly to inhibit the reabsorption of sodium chloride in the distal tubule anterior segment and the proximal tubule (less severe), thereby increasing the Na-K exchange in the distal tubule and the collecting duct, and increasing K+ secretion. Its mechanism of action is not yet fully understood. This type of drug can inhibit carbonic anhydrase activity to varying degrees, so it can explain its effect on the proximal tubule. This type of drug can also inhibit phosphodiesterase activity, reduce the tubular uptake of fatty acids and mitochondrial oxygen consumption, thereby inhibiting the active reabsorption of Na and Cl- by the tubule. ② Antihypertensive effect. In addition to the diuretic and sodium excretion effects, there may be extrarenal mechanisms involved in antihypertensive treatment, which may be to increase the excretion of Na in the gastrointestinal tract. 2. Effect on renal hemodynamics and glomerular filtration function. Due to the reduced reabsorption of water and Na by the renal tubules, the increased pressure within the renal tubules, and the increased water and Na flowing through the distal convoluted tubules, the macula densa is stimulated to increase the secretion of renin and angiotensin in the kidney through the tubular-glomerular reflex, causing renal vasoconstriction, decreased renal blood flow, constriction of the glomerular afferent and efferent arterioles, and a decrease in the glomerular filtration rate.

More

1. Effect on water and electrolyte excretion. ① Diuretic effect, increased excretion of urinary sodium, potassium, chloride, phosphorus and magnesium ions, and reduced excretion of urinary calcium. The mechanism of action of this type of drug is mainly to inhibit the reabsorption of sodium chloride in the distal tubule anterior segment and the proximal tubule (less severe), thereby increasing the Na-K exchange in the distal tubule and the collecting duct, and increasing K+ secretion. Its mechanism of action is not yet fully understood. This type of drug can inhibit carbonic anhydrase activity to varying degrees, so it can explain its effect on the proximal tubule. This type of drug can also inhibit phosphodiesterase activity, reduce the tubular uptake of fatty acids and mitochondrial oxygen consumption, thereby inhibiting the active reabsorption of Na and Cl- by the tubule. ② Antihypertensive effect. In addition to the diuretic and sodium excretion effects, there may be extrarenal mechanisms involved in antihypertensive treatment, which may be to increase the excretion of Na in the gastrointestinal tract. 2. Effect on renal hemodynamics and glomerular filtration function. Due to the reduced reabsorption of water and Na by the renal tubules, the increased pressure within the renal tubules, and the increased water and Na flowing through the distal convoluted tubules, the macula densa is stimulated to increase the secretion of renin and angiotensin in the kidney through the tubular-glomerular reflex, causing renal vasoconstriction, decreased renal blood flow, constriction of the glomerular afferent and efferent arterioles, and a decrease in the glomerular filtration rate.

58-93-5 56
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.